Source:http://linkedlifedata.com/resource/pubmed/id/10816291
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0018795,
umls-concept:C0033119,
umls-concept:C0034117,
umls-concept:C0041703,
umls-concept:C0205145,
umls-concept:C0205253,
umls-concept:C0205265,
umls-concept:C0221464,
umls-concept:C0349677,
umls-concept:C0993752,
umls-concept:C1522318,
umls-concept:C1555582,
umls-concept:C1948041
|
| pubmed:issue |
1
|
| pubmed:dateCreated |
2000-6-16
|
| pubmed:abstractText |
The aim of this first U.S. feasibility study was to investigate the safety and efficacy of a novel vascular sealing device, Duett, following percutaneous endovascular procedures. Immediately following a catheterization procedure, the sealing device was deployed at the femoral arterial access site in 43 patients (diagnostic 29, intervention 11, intervention + abciximab 3). Patients were followed up at 1 month with clinical assessment, ankle-brachial index measurement, and Doppler ultrasound of the treated femoral artery puncture site. Successful hemostasis was achieved with the Duett alone in 42/43 (97.7%) patients. There was one uncomplicated crossover to manual compression. The time to hemostasis was 4.0+/-1.5, 6.9+/-4.2, and 5.8+/-1.2 min for diagnostic, interventional, and abciximab patients, respectively. At 1-month follow-up, one patient (2.3%) required ultrasound-guided compression for treatment of a pseudoaneurysm. There were no other major complications. This novel vascular sealing device appears to achieve rapid and safe hemostasis successfully immediately following a wide range of percutaneous endovascular procedures.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
1522-1946
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
50
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
96-102
|
| pubmed:dateRevised |
2010-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:10816291-Adult,
pubmed-meshheading:10816291-Aged,
pubmed-meshheading:10816291-Analysis of Variance,
pubmed-meshheading:10816291-Angioplasty, Balloon, Coronary,
pubmed-meshheading:10816291-Catheters, Indwelling,
pubmed-meshheading:10816291-Equipment Design,
pubmed-meshheading:10816291-Feasibility Studies,
pubmed-meshheading:10816291-Female,
pubmed-meshheading:10816291-Femoral Artery,
pubmed-meshheading:10816291-Follow-Up Studies,
pubmed-meshheading:10816291-Heart Catheterization,
pubmed-meshheading:10816291-Hemorrhage,
pubmed-meshheading:10816291-Hemostatic Techniques,
pubmed-meshheading:10816291-Humans,
pubmed-meshheading:10816291-Male,
pubmed-meshheading:10816291-Middle Aged,
pubmed-meshheading:10816291-Probability,
pubmed-meshheading:10816291-Prospective Studies,
pubmed-meshheading:10816291-Punctures,
pubmed-meshheading:10816291-Sensitivity and Specificity,
pubmed-meshheading:10816291-Tissue Adhesives
|
| pubmed:year |
2000
|
| pubmed:articleTitle |
Immediate sealing of arterial puncture sites after cardiac catheterization and coronary interventions: initial U.S. feasibility trial using the Duett vascular closure device.
|
| pubmed:affiliation |
Department of Cardiology, Mpls. Heart Institute Foundation, Minneapolis, MN 55407, USA. mooney@allina.com
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|